Savient Pharma (SVNT) and Radware (RDWR) Debut On Takeover Target List
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Join SI Premium – FREE
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) and Radware Ltd. (Nasdaq: RDWR) have debuted on StreetInsider.com's "Top 50 Takeover Targets" list at M&A Central.
Savient Pharmaceuticals debuted at number 6, as the company has publicly disclosed it would seek a sale following approval of Krystexxa, which happened yesterday.
Radware Ltd (Nasdaq: RDWR) debuted at number 9, following reports from Globes that either HP (NYSE: HPQ) or IBM (NYSE: IBM) could be willing to pay as much as $1 billion for the company, or around $45/share.
Savient Pharmaceuticals debuted at number 6, as the company has publicly disclosed it would seek a sale following approval of Krystexxa, which happened yesterday.
Radware Ltd (Nasdaq: RDWR) debuted at number 9, following reports from Globes that either HP (NYSE: HPQ) or IBM (NYSE: IBM) could be willing to pay as much as $1 billion for the company, or around $45/share.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CoStar Group acquires Zonda for $800M, adding new home data
- TMCR raises $165M to acquire additional Mesabi iron ore royalty
- Virtu Financial said to explore $3.5B sales of brokerage unit
Create E-mail Alert Related Categories
Insiders' Blog, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
